ES521895A0 - Procedimiento de preparacion de benzoazacicloalquil-espiroimidazolidina, asi como de sus sales obtenidas con bases minerales u organicas farmaceuticamente aceptables. - Google Patents
Procedimiento de preparacion de benzoazacicloalquil-espiroimidazolidina, asi como de sus sales obtenidas con bases minerales u organicas farmaceuticamente aceptables.Info
- Publication number
- ES521895A0 ES521895A0 ES521895A ES521895A ES521895A0 ES 521895 A0 ES521895 A0 ES 521895A0 ES 521895 A ES521895 A ES 521895A ES 521895 A ES521895 A ES 521895A ES 521895 A0 ES521895 A0 ES 521895A0
- Authority
- ES
- Spain
- Prior art keywords
- espiroimidazolidina
- benzoazacicloalquil
- pharmaceutically
- well
- organic bases
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229910052500 inorganic mineral Inorganic materials 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 239000011707 mineral Substances 0.000 title 1
- 150000007530 organic bases Chemical class 0.000 title 1
- 238000002360 preparation method Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/38—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to acyclic carbon atoms and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/24—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/16—Benzazepines; Hydrogenated benzazepines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/10—Spiro-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Ophthalmology & Optometry (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8207203A FR2525603A1 (fr) | 1982-04-27 | 1982-04-27 | Benzoazacycloalkyl-spiro-imidazolinines, leur preparation et leur application en therapeutique |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ES8405796A1 ES8405796A1 (es) | 1984-06-16 |
| ES521895A0 true ES521895A0 (es) | 1984-06-16 |
Family
ID=9273425
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES521895A Granted ES521895A0 (es) | 1982-04-27 | 1983-04-27 | Procedimiento de preparacion de benzoazacicloalquil-espiroimidazolidina, asi como de sus sales obtenidas con bases minerales u organicas farmaceuticamente aceptables. |
Country Status (22)
| Country | Link |
|---|---|
| JP (1) | JPS5910584A (cg-RX-API-DMAC7.html) |
| KR (1) | KR840004428A (cg-RX-API-DMAC7.html) |
| AT (1) | ATA125383A (cg-RX-API-DMAC7.html) |
| AU (1) | AU1395383A (cg-RX-API-DMAC7.html) |
| BE (1) | BE896572A (cg-RX-API-DMAC7.html) |
| DD (1) | DD209833A5 (cg-RX-API-DMAC7.html) |
| DE (1) | DE3315106A1 (cg-RX-API-DMAC7.html) |
| DK (1) | DK183583A (cg-RX-API-DMAC7.html) |
| ES (1) | ES521895A0 (cg-RX-API-DMAC7.html) |
| FR (1) | FR2525603A1 (cg-RX-API-DMAC7.html) |
| GB (1) | GB2133401B (cg-RX-API-DMAC7.html) |
| GR (1) | GR78481B (cg-RX-API-DMAC7.html) |
| IL (1) | IL68497A0 (cg-RX-API-DMAC7.html) |
| IT (1) | IT1167123B (cg-RX-API-DMAC7.html) |
| LU (1) | LU84770A1 (cg-RX-API-DMAC7.html) |
| MA (1) | MA19783A1 (cg-RX-API-DMAC7.html) |
| NL (1) | NL8301476A (cg-RX-API-DMAC7.html) |
| NO (1) | NO831473L (cg-RX-API-DMAC7.html) |
| OA (1) | OA07412A (cg-RX-API-DMAC7.html) |
| PT (1) | PT76595B (cg-RX-API-DMAC7.html) |
| SE (1) | SE8302347L (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA832927B (cg-RX-API-DMAC7.html) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4927831A (en) * | 1988-10-20 | 1990-05-22 | American Home Products | Spiro-isoquinoline-pyrrolidine tetrones and analogs thereof useful as aldose reductase inhibitors |
| AU617541B2 (en) * | 1988-10-20 | 1991-11-28 | Wyeth | Spiro-isoquinoline-pyrrolidine tetrones and analogs thereof useful as aldose reductase inhibitors |
| US6953787B2 (en) | 2002-04-12 | 2005-10-11 | Arena Pharmaceuticals, Inc. | 5HT2C receptor modulators |
| SI2332921T1 (sl) | 2003-06-17 | 2016-06-30 | Arena Pharmaceuticals, Inc. | 8-kloro-1-metil-2,3,4,5-tetrahidro-1H-3-benzazapin hidroklorid |
| EA016558B1 (ru) | 2003-06-17 | 2012-05-30 | Арена Фармасьютикалз, Инк. | Производные бензазепина, используемые для лечения заболеваний, ассоциированных с 5-ht-рецептором |
| US8168624B2 (en) | 2004-12-21 | 2012-05-01 | Arena Pharmaceuticals, Inc. | Crystalline forms of (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine hydrochloride |
| EP2111859A1 (en) | 2004-12-23 | 2009-10-28 | Arena Pharmaceuticals, Inc. | 5HT2C receptor modulator compositions and methods of use |
| JP5199997B2 (ja) | 2006-04-03 | 2013-05-15 | アリーナ ファーマシューティカルズ， インコーポレイテッド | ８−クロロ−１−メチル−２，３，４，５−テトラヒドロ−１ｈ−３−ベンズアゼピンおよびこれに関連する中間体を調製するためのプロセス |
| WO2008070111A2 (en) | 2006-12-05 | 2008-06-12 | Arena Pharmaceuticals, Inc. | Processes for preparing (r)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine and intermediates thereof |
| CN102015591B (zh) | 2008-03-04 | 2014-01-29 | 艾尼纳制药公司 | 制备与5-ht2c激动剂(r)-8-氯-1-甲基-2，3，4，5-四氢-1h-3-苯并氮杂卓相关的中间体的方法 |
| WO2010148207A2 (en) | 2009-06-18 | 2010-12-23 | Arena Pharmaceuticals, Inc. | Processes for the preparation of 5-ht2c receptor agonists |
| WO2011153206A1 (en) | 2010-06-02 | 2011-12-08 | Arena Pharmaceuticals, Inc. | Processes for the preparation of 5-ht2c receptor agonists |
| CN103189360A (zh) | 2010-09-01 | 2013-07-03 | 艾尼纳制药公司 | 5-ht2c激动剂的非吸湿性盐 |
| KR20180094131A (ko) | 2010-09-01 | 2018-08-22 | 에자이 알앤드디 매니지먼트 가부시키가이샤 | 신장 손상을 갖는 개체에 대한 로카세린의 투여 |
| SG188362A1 (en) | 2010-09-01 | 2013-04-30 | Arena Pharm Inc | Modified-release dosage forms of 5-ht2c agonists useful for weight management |
| SG10201506870PA (en) | 2010-09-01 | 2015-10-29 | Arena Pharm Inc | Salts of lorcaserin with optically active acids |
| WO2014058441A1 (en) | 2012-10-09 | 2014-04-17 | Arena Pharmaceuticals, Inc. | Method of weight management |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4209630A (en) * | 1976-10-18 | 1980-06-24 | Pfizer Inc. | Hydantoin derivatives as therapeutic agents |
| US4235911A (en) * | 1979-06-13 | 1980-11-25 | Pfizer Inc. | Hydantoin derivatives |
-
1982
- 1982-04-27 FR FR8207203A patent/FR2525603A1/fr active Granted
-
1983
- 1983-04-08 AT AT0125383A patent/ATA125383A/de not_active IP Right Cessation
- 1983-04-25 LU LU84770A patent/LU84770A1/fr unknown
- 1983-04-25 DD DD83250187A patent/DD209833A5/de unknown
- 1983-04-26 ZA ZA832927A patent/ZA832927B/xx unknown
- 1983-04-26 BE BE0/210633A patent/BE896572A/fr not_active IP Right Cessation
- 1983-04-26 IT IT48155/83A patent/IT1167123B/it active
- 1983-04-26 NO NO831473A patent/NO831473L/no unknown
- 1983-04-26 DK DK183583A patent/DK183583A/da not_active Application Discontinuation
- 1983-04-26 PT PT76595A patent/PT76595B/pt unknown
- 1983-04-26 IL IL68497A patent/IL68497A0/xx unknown
- 1983-04-26 JP JP58073687A patent/JPS5910584A/ja active Pending
- 1983-04-26 SE SE8302347A patent/SE8302347L/xx not_active Application Discontinuation
- 1983-04-26 NL NL8301476A patent/NL8301476A/nl not_active Application Discontinuation
- 1983-04-26 GR GR71214A patent/GR78481B/el unknown
- 1983-04-26 AU AU13953/83A patent/AU1395383A/en not_active Abandoned
- 1983-04-26 KR KR1019830001753A patent/KR840004428A/ko not_active Withdrawn
- 1983-04-27 DE DE19833315106 patent/DE3315106A1/de not_active Withdrawn
- 1983-04-27 OA OA57984A patent/OA07412A/xx unknown
- 1983-04-27 ES ES521895A patent/ES521895A0/es active Granted
- 1983-04-27 GB GB08311508A patent/GB2133401B/en not_active Expired
- 1983-04-27 MA MA20003A patent/MA19783A1/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| GB8311508D0 (en) | 1983-06-02 |
| DE3315106A1 (de) | 1983-11-03 |
| GB2133401A (en) | 1984-07-25 |
| PT76595A (fr) | 1983-05-01 |
| SE8302347D0 (sv) | 1983-04-26 |
| FR2525603A1 (fr) | 1983-10-28 |
| FR2525603B1 (cg-RX-API-DMAC7.html) | 1984-09-14 |
| DK183583D0 (da) | 1983-04-26 |
| NL8301476A (nl) | 1983-11-16 |
| SE8302347L (sv) | 1983-10-28 |
| GB2133401B (en) | 1985-10-23 |
| ATA125383A (de) | 1986-05-15 |
| NO831473L (no) | 1983-10-28 |
| ZA832927B (en) | 1984-06-27 |
| ES8405796A1 (es) | 1984-06-16 |
| OA07412A (fr) | 1984-11-30 |
| IT8348155A0 (it) | 1983-04-26 |
| MA19783A1 (fr) | 1983-12-31 |
| IL68497A0 (en) | 1983-07-31 |
| DK183583A (da) | 1983-10-28 |
| LU84770A1 (fr) | 1984-11-28 |
| KR840004428A (ko) | 1984-10-15 |
| JPS5910584A (ja) | 1984-01-20 |
| GR78481B (cg-RX-API-DMAC7.html) | 1984-09-27 |
| BE896572A (fr) | 1983-10-26 |
| DD209833A5 (de) | 1984-05-23 |
| PT76595B (fr) | 1986-01-21 |
| AU1395383A (en) | 1983-11-03 |
| IT1167123B (it) | 1987-05-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IT8322801A0 (it) | Procedimento per la produzione di idrocarburi. | |
| ES521895A0 (es) | Procedimiento de preparacion de benzoazacicloalquil-espiroimidazolidina, asi como de sus sales obtenidas con bases minerales u organicas farmaceuticamente aceptables. | |
| IT8719199A0 (it) | Procedimento per la produzione di benzina. | |
| ES510167A0 (es) | Procedimiento para la produccion de n-acilo-polipeptidos. | |
| IT8222414A0 (it) | Processo per la preparazione dicomposti organici. | |
| IT7926935A0 (it) | Procedimento eterogeneo per lapreparazione di 1,1-diesteri. | |
| IT8023087A0 (it) | Procedimento per la produzione di p-cloroalchilbenzene. | |
| IT8023163A0 (it) | Processo per la preparazione dicomposti organici carbossilati. | |
| IT7927658A0 (it) | Processo per la preparazione di idrocarburi. | |
| IT8523143A0 (it) | Procedimento per il consolidamento di terreni. | |
| ES2016964B3 (es) | Procedimiento para la preparacion de bitumen. | |
| IT8025261A0 (it) | Procedimento per la produzione di teatrafluoruro di zolfo. | |
| IT7925114A0 (it) | Procedimento per la fabbricazione di chiodi. | |
| ES542835A0 (es) | Procedimiento de preparar un antigeno relacionado con el ligamento glicosidico,derivado de celulas de cancer. | |
| ES510596A0 (es) | Procedimiento para la obtencion de 3-alquen-i-il-2,3-dimetil-ciclopropancarboxilatos de 4-fluor-3-fenoxi-bencilo. | |
| ES545018A0 (es) | Procedimiento de preparar agentes de fluoracion de compuestos organicos. | |
| IT7927802A0 (it) | Processo per la preparazione di idrocarburi. | |
| IT8122146A0 (it) | Procedimento per la produzione di mercapto-2-etanolo-1. | |
| NO863343L (no) | Fremgangsmaate for fremstilling av gem-dihalo-1,8-diamino-4-aza-octaner. | |
| IT7922961A0 (it) | Procedimento per la produzione dicomposti cianici. | |
| DK212783D0 (da) | Fremgangsmade til fremstilling af melasseholdige, mineralske fodermidler | |
| IT8021231A0 (it) | Procedimento per la preparazione di 2-amminopirazine sostituite. | |
| ES507373A0 (es) | Procedimiento para el apresto de cables. | |
| FI833886A7 (fi) | Menetelmä orgaanisten hyponitriittien valmistamiseksi. | |
| IT8024757A0 (it) | Procedimento per la produzione di uricasi. |